Phase 1/2 Study of CG200745 PPA for Myelodysplastic Syndrome

Clinical trial NCT02737462 · UNKNOWN

Trial details

NCT number: NCT02737462
Sponsor: CrystalGenomics, Inc.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndrome

Start date: 2016-06-01
Primary completion: 2022-12-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.